SAT-076 - Ramucirumab as Second-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Analysis of Reach Patients by Albumin-Bilirubin (ALBI) Grade
| Autor: | Blanc, J.-F., Chan, S.L., Park, J.O., Ryoo, B.-Y., Yen, C.-J., Kudo, M., Poon, R., Pastorelli, D., Baron, A., Pfiffer, T.F., Okusaka, T., Kubackova, K., Trojan, J., Sastre, J., Chau, I., Abada, P., Chang, S.-C., Yang, L., Zhu, A. |
|---|---|
| Zdroj: | In Journal of Hepatology 2016 64(2) Supplement:S693-S694 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect